Michael Ott
Pulmonary Disease · Eglin Afb, FLNPI 1629052725
Payments from drug & device makers
$909,084in general payments, 2019–2025
Across 1,110 payments — averaging $818.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$903K
- Grifols USA, LLC$5K
- Viiv Healthcare Company$600
- Boehringer Ingelheim$345
- Vapotherm Inc$101
- Inspire Medical Systems, Inc.$34
- plus $119 from 6 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1,079 | $902,783 |
| Grifols USA, LLC | 6 | $5,102 |
| Viiv Healthcare Company | 1 | $600 |
| Boehringer Ingelheim | 11 | $345 |
| Vapotherm Inc | 4 | $101 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Gilead | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Merck | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Boston Scientific | 1 | $14 |
How this compares
$909,084 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Eglin Afb
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.